To predict out-of-pocket costs patients could face after insurance companies stop absorbing COVID-19 hospitalization costs, two healthcare researchers from the Ann Arbor-based University of Michigan and Boston University examined data from 14,278 Medicare Advantage patients hospitalized for influenza in 2018.
These flu patients stayed in the hospital for an average of six days, and about one-third of them needed intensive care. Both measures are around the same or slightly lower than the averages for Medicare Advantage patients hospitalized for COVID-19.
Analysis of the flu-related hospital bills suggested patients hospitalized for severe COVID-19 could face an average out-of-pocket cost over $1,000 due to deductibles, copays and coinsurance. The researchers predicted patients who require intensive care or have longer stays at any care level will face out-of-pocket costs higher than the general average, as about 3 percent of the flu patients examined in the study faced out-of-pocket costs over $2,500.
Patients who have private non-Medicare insurance could face even higher costs, as private plans often have high deductibles that must be paid each year before coverage fully initiates.
More articles on healthcare finance:
Cap on hospital rates carries bigger savings reward than price transparency, study finds
Prisma Health’s net income more than triples
New York governor: Cap profits on nursing homes
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
